Viral Vaccines Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

A vaccine is normally made from a disease-causing microorganism that has been weakened or destroyed. Vaccines are biological preparations that boost immunity to a specific disease. They're usually made from living organisms. Vaccines that cure diseases are known as therapeutic vaccines, and vaccines that prevent disease are known as prophylactic vaccines. With the increase in prevalence of several infectious and non-infectious diseases, as well as technological advancements the viral vaccines market is growing. In addition, the market is projected to expand due to a large number of vaccination programs supported by government and non-government institutes, and a rise in demand for combined vaccines.

MARKET DYNAMICS

Factors driving the growth of the viral vaccines market are high predominance of chronic diseases, and growing importance of immunization across the globe. However, lack of healthcare infrastructure in the developing nations is likely to hamper the growth of the market. Moreover, technology advancements in the viral vaccines is further likely to create growth opportunities in the market.

MARKET SCOPE

The "Viral Vaccines Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of viral vaccines market with detailed market segmentation by type of vaccine, route of administration, and distribution channel. The viral vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in viral vaccines market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The viral vaccines market is segmented on the basis of type of vaccine, route of administration, and distribution channel. On the basis of type of vaccine, the market is categorized as preventive, and therapeutic. On the basis of route of administration, the market is categorized as oral, and injectable. On the basis of distribution channel, the market is categorized as hospital pharmacies, online pharmacies, and research institutes.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the viral vaccines market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The viral vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting viral vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the viral vaccines market in these regions.

Viral Vaccines Market Report Analysis

Viral Vaccines Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• GlaxoSmithKline Plc
• Sanofi
• Novartis, Inc.
• MedImmune, LLC
• Protein Sciences Corporation
• Serum Institute of India Ltd.
• Seqirus
• Emergent Product Development Gaithersburg, Inc.
• Merck & Co., Inc.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Type of Vaccine

• Preventive
• Therapeutic

By Route of Administration

• Oral
• Injectable

By Distribution Channel

• Hospital Pharmacies
• Online Pharmacies
• Research Institutes

MARKET PLAYERS

The report covers key developments in the viral vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from viral vaccines market are anticipated to have lucrative growth opportunities in the future with the rising demand for viral vaccines in the global market. Below mentioned is the list of few companies engaged in the viral vaccines market.

The report also includes the profiles of key players in viral vaccines market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

•   GlaxoSmithKline Plc
  
•   Sanofi
  
•   Novartis, Inc.
  
•   MedImmune, LLC
  
•   Protein Sciences Corporation
  
•   Serum Institute of India Ltd.
  
•   Seqirus
  
•   Emergent Product Development Gaithersburg, Inc.
  
•   Merck & Co., Inc.
  
•   Bharat Biotech
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Viral Vaccines Market Report Scope